Overactive Bladder Treatment Market Analysis: Major Players, Lucrative Segments And Top Geographies
9 Jun, 2023
The global overactive bladder treatment market size is expected to grow from $2.90 billion in 2022 to $3.01 billion in 2023 at a compound annual growth rate (CAGR) of 3.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global overactive bladder treatment market size is expected to reach $3.51 billion in 2027 at a CAGR of 3.9%.
Global Overactive Bladder Treatment Market Key Driver
A growing geriatric population is likely to drive future growth in the overactive bladder therapy industry. The geriatric population is defined as those aged 65 and older. Geriatric people are more susceptible to urinary tract infections for a variety of reasons, including decreased urine flow, an overactive bladder, an enlarged prostate, or kidney stones. This will increase demand for therapies for overactive bladder.
Get a sample of the global overactive bladder treatment market reportGlobal Overactive Bladder Treatment Market Segments
The global overactive bladder treatment market is segmented:
1) By Diseases Type: Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity
2) By Therapy: Anticholinergics, Mirabegron, Neurostimulation, Intravesical Instillation, Other Therapies
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
4) By Geography: The regions covered in the overactive bladder treatment market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global overactive bladder treatment market.
Major Overactive Bladder Treatment Industry Players
AbbVie Inc., Astellas Pharma Inc., Laborie, Endo International Plc., Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson Services Inc., Medtronic Plc., Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Limited, Cogentix Medical Inc., Dr. Reddy’s Laboratories Ltd., Sumitomo Pharma Co. Ltd, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Limited
Get the full global overactive bladder treatment market report
Overactive Bladder Treatment Market Overview
Overactive bladder refers to a collection of symptoms that may affect how often a person pees and the urgency. Treatment includes changing certain behaviours and incorporating pelvic floor muscle exercises, and others to eliminate symptoms. Treatment can be helpful for relieving the symptoms of an overactive bladder and reducing episodes of urgent incontinence.
Overactive Bladder Treatment Global Market Report 2023 provides data on the global overactive bladder treatment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The overactive bladder treatment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.